Health ❯ Healthcare ❯ Clinical Trials ❯ Efficacy Studies

DEVOTE Study

FDA Approves Higher‑Dose Spinraza Regimen for Spinal Muscular Atrophy

The new option follows trial results that showed larger motor‑function gains in infants at the higher dose.